S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.33
+1.65
+9.89%
IMA · ImageneBio, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$4.15
+0.05
(+1.22%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$4.15
$4.15
$4.15
52-WEEK RANGE
$4.15
$3.90
$9.10
What's happening
- IMA is up 1.22% today, trading at $4.15. — Live quote
- Volume today (315) is well below its 3-month average of 13,030. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (after market close), 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.63 actual vs. $-0.90 estimated (+30.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 3
Hold 1
Sell 0
Strong sell 1
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IMA
-40.14%
vs S&P 500
-52.92%
1-YEAR RETURN
IMA
-45.51%
vs S&P 500
-60.08%
6-MONTH RETURN
IMA
-28.55%
3-MONTH RETURN
IMA
-31.17%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.63
Est. $-0.90
BEAT +30.3%
2026-04-26 (Q1 2026)
$-0.95
Est. $-0.71
MISS -33.7%
2026-01-26 (Q4 2025)
$-1.42
Est. $-1.46
BEAT +2.8%
2025-10-26 (Q3 2025)
$-2.91
Est. $-1.29
MISS -125.1%
Valuation Measures & Ratios
Enterprise Value4-$47.8M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)5.12
Price / Book70.47
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin-744.28%
Operating Margin-823.43%
Return on Equity (ROE8)-38.99%
Return on Assets (ROA9)-34.84%
Avg Volume (3M)13,030
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $98.2M | $53.5M | $68.0M | $27.3M | $24.5M |
| P/E | -1.85 | -1.09 | -1.63 | -1.18 | -0.65 |
| Price/Book | 0.69 | 0.43 | 0.49 | -0.15 | -0.14 |
| ROE | -37.42% | -39.78% | -29.77% | 12.81% | 22.31% |
| ROA | -34.96% | -35.89% | -25.87% | -18.31% | -28.92% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short32,852
Change from Prior Settlement-5.05%
% of Float—
Days to Cover (Short Ratio)1.90
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-08-17; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -38.6% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -744.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -45.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IMA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $800.0K | $3.5M | — | — |
| Operating income | -$11.8M | -$12.1M | -$26.6M | -$7.4M | -$6.0M | -$2.0M | -$15.8M | -$18.2M |
| Net income | -$10.2M | -$10.6M | -$24.8M | -$7.6M | -$6.1M | -$3.2M | -$6.3M | -$22.3M |
| EPS (diluted) | $-0.63 | $-0.95 | $-2.91 | $-4.46 | $-3.80 | $-2.58 | $-0.28 | $-0.33 |
| EPS (basic) | $-0.63 | $-0.95 | $-2.91 | $-4.46 | $-3.80 | $-2.58 | $-0.28 | $-0.33 |
| Operating margin | — | — | — | — | -$749 | -$58 | — | — |
| Net margin | — | — | — | — | -$760 | -$91 | — | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $152.0M | $136.7M | $153.0M | $160.9M | $126.2M | $130.8M | $15.9M | $149.0M |
| Total liabilities | $10.0M | $13.4M | $19.8M | $21.0M | $10.3M | $12.6M | $17.4M | $14.8M |
| Stockholders' equity | $142.1M | $123.3M | $133.1M | $139.8M | -$180.4M | -$169.6M | -$160.6M | -$152.8M |
| Total current assets | $141.1M | $122.0M | $140.3M | $147.5M | $99.0M | $117.0M | $12.5M | $141.5M |
| Total current liabilities | $6.6M | $6.6M | $11.2M | $11.1M | $7.3M | $8.8M | $17.2M | $9.2M |
| Cash & equivalents | $94.7M | $76.0M | $94.5M | $103.2M | $58.3M | $36.8M | $12.1M | $45.2M |
| Marketable securities (current) | $41.5M | $41.2M | $40.8M | $39.4M | $37.4M | $77.3M | $0 | $92.8M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | — | — | $0 | $1.0K | $419.0K | $506.0K | $8.0K | $682.0K |
| Other non-current assets | — | — | $4.9M | $5.0M | — | — | $1.0M | — |
| Accounts payable | $977.0K | $568.0K | $1.4M | $2.1M | $512.0K | $805.0K | $5.3M | $1.5M |
| Deferred revenue (current) | — | — | $0 | $0 | — | — | $650.0K | — |
| Other current liabilities | $250.0K | $316.0K | $164.0K | — | $39.0K | $140.0K | $23.0K | $47.0K |
| Other non-current liabilities | $838.0K | $881.0K | $870.0K | $1.1M | $1.1M | $1.1M | $0 | $1.0M |
| Common stock & paid-in capital | — | — | — | — | $48.0K | $48.0K | $48.0K | $48.0K |
| Retained earnings | -$250.8M | -$240.7M | -$230.1M | -$223.1M | -$343.0M | -$340.2M | -$179.9M | -$322.5M |
| Accumulated other comprehensive income (loss) | -$51.0K | -$17.0K | $87.0K | $94.0K | $65.0K | $99.0K | -$1.8M | $240.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.1M | -$14.8M | -$7.2M | -$21.5M | -$11.9M | -$7.2M | -$3.5M | $13.0M |
| Investing cash flow | -$346.0K | -$440.0K | -$1.4M | -$4.5M | $0 | $0 | $103.0K | $55.8M |
| Financing cash flow | $28.0M | -$3.2M | $0 | $122.4M | $13.0M | $27.0K | $6.9M | $0 |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | — | — | $400.0K | — | — | — | $1.1M | — |
| Share-based compensation | $911.0K | $876.0K | $51.0K | $15.3M | $0 | $57.0K | $0 | -$3.3M |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts payable | $409.0K | -$871.0K | -$641.0K | -$3.1M | -$464.0K | $1.4M | $1.7M | -$1.6M |
| Purchases of investments | $8.0M | $10.9M | $8.9M | $1.5M | $0 | $0 | $0 | -$72.3M |
| Sales/maturities of investments | — | — | — | — | $37.4M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | $0 | — | $0 | $0 | $15.0M | — | $7.5M | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $800.0K | $3.5M | $9.2M | $15.6M | $31.0M |
| Operating income | -$48.5M | -$37.0M | -$75.4M | -$70.9M | -$34.1M |
| Net income | -$45.3M | -$36.6M | -$68.2M | -$68.8M | -$34.1M |
| EPS (diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 |
| EPS (basic) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 |
| Operating margin | -$6.1K | -$1.1K | -$823 | -$454 | -$110 |
| Net margin | -$5.7K | -$1.0K | -$744 | -$440 | -$110 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $153.0M | $15.9M | $192.1M | $172.3M | $247.9M |
| Total liabilities | $19.8M | $17.4M | $22.3M | $25.3M | $40.0M |
| Stockholders' equity | $133.1M | -$160.6M | -$126.1M | $147.0M | $207.9M |
| Total current assets | $140.3M | $12.5M | $178.7M | $160.0M | $236.5M |
| Total current liabilities | $11.2M | $17.2M | $14.2M | $21.5M | $27.2M |
| Cash & equivalents | $94.5M | $12.1M | $119.9M | $59.9M | $232.2M |
| Marketable securities (current) | $40.8M | $0 | $55.6M | $97.0M | — |
| Other current assets | — | — | $1.1M | $964.0K | $629.0K |
| Property, plant & equipment | $0 | $8.0K | $2.3M | $3.2M | $2.4M |
| Other non-current assets | $4.9M | $1.0M | — | — | — |
| Accounts payable | $1.4M | $5.3M | $2.1M | $2.1M | $2.4M |
| Deferred revenue (current) | $0 | $650.0K | — | — | — |
| Other current liabilities | — | $23.0K | $85.0K | $119.0K | $26.0K |
| Other non-current liabilities | $870.0K | $0 | — | — | — |
| Common stock & paid-in capital | — | $48.0K | $48.0K | $36.0K | $36.0K |
| Retained earnings | -$230.1M | -$179.9M | -$282.4M | -$214.2M | -$145.5M |
| Accumulated other comprehensive income (loss) | $87.0K | -$1.8M | -$48.0K | -$763.0K | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$47.8M | -$21.3M | -$79.7M | -$74.1M | -$60.3M |
| Investing cash flow | -$5.8M | $11.1M | $64.1M | -$99.3M | -$1.8M |
| Financing cash flow | $135.5M | $6.9M | $76.0M | $1.1M | $131.7M |
| Free cash flow | — | — | -$80.2M | -$75.5M | -$62.0M |
| Capital expenditures | — | — | $414.0K | $1.4M | $1.8M |
| Depreciation & amortization | $400.0K | $1.1M | — | — | — |
| Share-based compensation | $15.4M | $0 | $7.6M | $7.5M | $5.2M |
| Deferred income taxes | $0 | $0 | — | — | — |
| Change in accounts payable | -$2.8M | -$523.0K | -$2.9M | -$291.0K | $361.0K |
| Purchases of investments | $10.4M | $0 | $90.1M | $216.3M | — |
| Share repurchases | — | — | $663.0K | — | — |
| Debt issued | $15.0M | $7.5M | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IMA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-07-25 to 2026-08-14
Recent transactions
- Insiders have net sold 3,196 shares over the last 182 days, across 0 purchases and 2 sales.
- Most recent: Yarema Kristin (Chief Executive Officer) — Grant / award of 254,800 shares on 2026-08-14.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)3,196 sh(2 txns)
Net Shares-3,196
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Yarema Kristin | Chief Executive Officer | Grant / award | 2026-08-14 | 254,800 |
| Grant-Huerta Yanina | Chief Financial Officer | Grant / award | 2026-08-14 | 65,000 |
| Lally Robert B | Principal Accounting Officer | Open market sale | 2026-07-17 | 1,525 |
| Butler Erin | Principal Accounting Officer | Grant / award | 2025-12-30 | 22,500 |
| SLATTERY JOSEPH P | Reporting person | Open market purchase | 2025-12-24 | 16,000 |
| Marango Jotin | Chief Financial Officer | Grant / award | 2025-07-28 | 15,776 |
| Wang Stephen Hui | Reporting person | Grant / award | 2025-07-25 | 188,042 |
| Wang Jonathan Jian | Reporting person | Grant / award | 2025-07-25 | 143,832 |
| ORBIMED ADVISORS LLC | Director | Grant / award | 2025-07-25 | 83,611 |
| Bonita David P | Reporting person | Option exercise | 2025-07-25 | 379 |
| Stampacchia Otello | Reporting person | Option exercise | 2025-07-25 | 379 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-14 | Yarema Kristin | Chief Executive Officer | Grant / award | 254,800 | $0.00 |
| 2026-08-14 | Grant-Huerta Yanina | Chief Financial Officer | Grant / award | 65,000 | $0.00 |
| 2026-08-14 | Grant-Huerta Yanina | Chief Financial Officer | Grant / award | 39,000 | $0.00 |
| 2026-07-25 | Yarema Kristin | Chief Executive Officer | Option exercise | 38,376 | $0.00 |
| 2026-07-25 | Yarema Kristin | Chief Executive Officer | Other acquisition/disposition | 115,129 | $0.00 |
| 2026-07-17 | Lally Robert B | Principal Accounting Officer | Open market sale | 1,525 | $5.34 |
| 2026-07-16 | Lally Robert B | Principal Accounting Officer | Open market sale | 1,671 | $5.50 |
| 2026-03-16 | Yarema Kristin | Chief Executive Officer | Grant / award | 85,400 | $0.00 |
| 2025-12-30 | Butler Erin | Principal Accounting Officer | Grant / award | 22,500 | $0.00 |
| 2025-12-24 | SLATTERY JOSEPH P | Reporting person | Open market purchase | 16,000 | $5.99 |
| 2025-07-28 | Marango Jotin | Chief Financial Officer | Grant / award | 15,776 | — |
| 2025-07-28 | Marango Jotin | Chief Financial Officer | Tax withholding | 4,630 | $17.16 |
| 2025-07-25 | Wang Stephen Hui | Reporting person | Grant / award | 188,042 | — |
| 2025-07-25 | Wang Stephen Hui | Reporting person | Grant / award | 50,144 | — |
| 2025-07-25 | Wang Stephen Hui | Reporting person | Grant / award | 12,535 | — |
| 2025-07-25 | Wang Jonathan Jian | Reporting person | Grant / award | 143,832 | — |
| 2025-07-25 | Wang Jonathan Jian | Reporting person | Grant / award | 971,173 | — |
| 2025-07-25 | ORBIMED ADVISORS LLC | Director | Grant / award | 83,611 | $2.49 |
| 2025-07-25 | Bonita David P | Reporting person | Option exercise | 379 | — |
| 2025-07-25 | Bonita David P | Reporting person | Open market purchase | 83,611 | $29.90 |
| 2025-07-25 | Stampacchia Otello | Reporting person | Option exercise | 379 | — |
| 2025-07-25 | Stampacchia Otello | Reporting person | Open market purchase | 267,556 | $29.90 |
| 2025-07-25 | Butler Erin | Principal Accounting Officer | Grant / award | 3,051 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 09:05 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-17 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-17 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-28 | 4 | 2026-07-25 | View on SEC.gov → |
| 2026-07-23 | 8-K | 2026-07-20 | View on SEC.gov → |
| 2026-07-20 | 4 | 2026-07-16 | View on SEC.gov → |
| 2026-06-26 | 8-K | 2026-06-22 | View on SEC.gov → |
| 2026-06-18 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-06-18 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-06-18 | 4 | 2026-06-16 | View on SEC.gov → |
| 2026-06-18 | 4 | 2026-06-16 | View on SEC.gov → |
Recent news
Headlines about IMA (ImageneBio, Inc.). Links open the publisher — we don’t host full articles.
-
Securities firms race to expand size amid IMA, investment bank push, raise 8.7 trillion won
디지털투데이 · 2026-10-18 -
Korea Investment & Securities expands IMA to defend lead as CP competition rises - CHOSUNBIZ
Chosunbiz · 2026-10-18 -
ImageneBio grants 90,775 units: ImageneBio stock sits 55.71 percent below its high - ad-hoc-news.de
ad-hoc-news.de · 2026-10-16 -
American Tungsten (TSXV:TUNG) Slides 8.97%: IMA Mine Development Lead Times, Critical Mineral Pacing, and Junior Mining Multiple Compression Weigh on Valuation
kalkine.ca · 2026-10-15 -
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · 2026-10-02 -
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
Yahoo Finance · 2026-09-08 -
ImageneBio, Inc. GAAP EPS of -$0.63
Seeking Alpha · 2026-08-05 -
ImageneBio Reports Second Quarter 2026 Financial Results
Yahoo Finance · 2026-08-05
No headlines in this category right now — try “All”.